✦ LIBER ✦

Fatigue and daytime somnolence in Machado Joseph Disease (spinocerebellar ataxia type 3)

✍ Scribed by Joseph H. Friedman; Melissa M. Amick

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 275 KB
Volume: 23
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.22122

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular and clinical correlations in s

Molecular and clinical correlations in spinocerebellar ataxia type 3 and Machado-Joseph disease

✍ Toni Matilla; Alanna McCall; S. H. Subramony; Dr Huda Y. Zoghbi 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

REM behavior disorder and excessive dayt

REM behavior disorder and excessive daytime somnolence in Machado–Joseph disease (SCA-3)

✍ Joseph H. Friedman; Hubert H. Fernandez; Lewis R. Sudarsky 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

## Abstract We reported previously that behavior suggestive of rapid eye movement sleep behavior disorder (RBD) was markedly increased in a small population of SCA‐3 patients. We, therefore, asked patients and nonpatient attendees at an SCA‐3 annual clinic to complete a questionnaire soliciting RBD

Presumed rapid eye movement behavior dis

Presumed rapid eye movement behavior disorder in Machado-Joseph disease (spinocerebellar ataxia type 3)

✍ Joseph H. Friedman 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB

Rapid eye movement behavior disorder (RBD) is a recently recognized sleep disorder in which patients are occasionally not paralyzed during the dream portions of sleep. When not idiopathic, this state has been associated primarily with parkinsonian conditions but also with a small number of medicatio

Spinocerebellar ataxia 3 and machado-jos

Spinocerebellar ataxia 3 and machado-joseph disease: Clinical, molecular, and neuropathological features

✍ Dr Alexandra Durr; Giovanni Stevanin; Geraldine Cancel; Charles Duyckaerts; Nace 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 981 KB

Botulinum toxin type A for treatment of

Botulinum toxin type A for treatment of spasticity in spinocerebellar ataxia type 3 (Machado–Joseph disease)

✍ William Freeman; Zbigniew Wszolek 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB

Somatic mosaicism of the CAG repeat expa

Somatic mosaicism of the CAG repeat expansion in spinocerebellar ataxia type 3/Machado-Joseph disease

✍ Géraldine Cancel; Isabelle Gourfinkel-An; Giovanni Stevanin; Olivier Didierjean; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 1 views

An expanded and unstable CAG repeat in the coding region of the MJD1 gene is the mutation responsible for spinocerebellar ataxia 3/Machado-Joseph disease. In order to determine whether there was a higher degree of instability in affected regions, the size of the expanded CAG repeat was analyzed in d